Brookdale Senior Living Earnings Call Transcripts
Fiscal Year 2026
-
Leadership is driving an operational transformation with new hires and a regional structure, focusing on market-level execution and empowering executive directors. Strong demand and limited new supply support favorable occupancy and pricing, while CapEx and M&A strategies target ROI and market gaps. Labor costs are well-managed, with inflation pressures moderating.
-
Occupancy and EBITDA are set to accelerate as the company stabilizes its portfolio at 517 communities, leverages demographic tailwinds, and deploys comprehensive CapEx and operational initiatives. The new regional structure and targeted market strategies are expected to drive multi-year growth and margin expansion.
Fiscal Year 2025
-
Delivered strong 2025 results with 19% Adjusted EBITDA growth and record occupancy, driven by operational improvements and portfolio optimization. 2026 guidance calls for 8%-9% RevPAR growth and mid-teen Adjusted EBITDA expansion, supported by favorable demographics and targeted capital investment.
-
Q3 2025 saw record post-pandemic occupancy and 20% adjusted EBITDA growth, prompting a guidance raise. Portfolio optimization and targeted CapEx are driving performance, while a new CEO and regional structure aim to accelerate operational gains.
-
Occupancy surpassed 80%, driving improved cash flow and leverage, with further gains expected as portfolio rationalization continues. HealthPlus is delivering strong clinical and financial outcomes, while targeted CapEx and marketing investments support growth. Favorable industry trends and operational leverage position the business for sustainable expansion.
-
Q2 saw occupancy rise above 80% for the first time since 2020, driving 20% adjusted EBITDA growth and positive free cash flow. Portfolio optimization and cost controls supported improved guidance for RevPAR and EBITDA, with further asset dispositions and reinvestment planned.
-
Strong occupancy and cash flow gains were driven by higher move-ins, internal marketing, and portfolio optimization. The Health Plus initiative is expanding, supporting rent growth and lower staff turnover. Strategic asset dispositions and a focus on reducing leverage continue, while a CEO search prioritizes operational expertise.
-
Q1 2025 saw RevPAR and adjusted EBITDA exceed expectations, prompting raised annual guidance. Operational improvements, asset optimization, and targeted investments are driving occupancy and cash flow, while leadership transition and board refreshment continue.
-
Senior living operator reported accelerating occupancy growth, improved financials, and strong momentum into 2024 and 2025. Internal marketing and innovative care programs drive performance, while limited new supply and demographic trends support long-term growth.
-
Senior living is set for strong growth, driven by favorable demographics and limited new supply. Operational recovery is robust, with occupancy and RevPAR above pre-pandemic levels, and clinical programs like Health Plus delivering superior outcomes. Positive free cash flow and strategic real estate acquisitions support long-term value.
Fiscal Year 2024
-
Q4 and full-year results exceeded guidance, with strong RevPAR, EBITDA, and improved cash flow. Strategic portfolio actions, debt refinancing, and operational initiatives position the company for 2025 growth, with guidance for 11%-15% EBITDA increase and continued positive free cash flow.
-
Consistent occupancy and revenue growth, strategic acquisitions, and constrained supply are driving improved cash flow and operational performance. Focused on workforce retention, capital allocation, and expanding the HealthPlus program, the outlook for 2025 remains positive amid favorable demographic trends.
-
Q3 saw 15% adjusted EBITDA growth, 80 bps sequential occupancy gain, and $14M in free cash flow. Accretive acquisitions and debt refinancing position the company for continued growth, with Q4 guidance reflecting higher RevPOR and occupancy, despite hurricane and insurance cost headwinds.
-
Q2 2024 saw 20% Adjusted EBITDA growth and 26% higher Adjusted Free Cash Flow year-over-year, with strong margin expansion and continued operational improvements. Guidance for Q3 anticipates further RevPAR and EBITDA growth, supported by robust demand and disciplined expense management.